Accendra Health (ACH) investor relations material

Executive summary

• Special meeting proposals seek authorization for a 1-for-20 to 1-for-30 reverse stock split, at the Board’s discretion, and a corresponding reduction in authorized common shares; the Board unanimously recommends FOR both.

• The split is intended to address NYSE minimum-price noncompliance; shareholders of record on October 27, 2026 are eligible to vote.

Voting matters and shareholder proposals

• Reverse Split Proposal requires approval by a majority of outstanding common shares; abstentions count against it.

• Adjournment Proposal passes if votes FOR exceed votes AGAINST; abstentions have no effect.

• If support is insufficient, approval of adjournment would allow additional proxy solicitation, including seeking vote changes from shareholders who opposed the split.

Board of directors and corporate governance

• The Board may select the final split ratio and implementation timing, and may abandon the proposal before it takes effect even if shareholders approve it.

• The Board unanimously supports both proposals and determined seeking approval of the reverse split is in shareholders’ best interests.